"While there are many drugs used to treat type 2 diabetes (sulfonylureas, DPP-4 inhibitors, SGLT-2 inhibitors, TZDs, GLP-1 agonists, etc.), these results may make Jardiance or other SGLT-2 inhibitors the standard second-line therapy (after metformin) used to treat type 2 diabetes (or potentially first-line therapy if the magnitude is really meaningful we wont know anything about that for a month, when the specifics on the results are disclosed)
Key Safety Screening Questions for Crohn's Patients Considering GLP-1 Before starting any GLP-1 medication, Crohn's patients and providers should evaluate disease stability, recent imaging, stricture history, and current immunosuppressive therapy
But look at how some news stories interpreted this study for the public
Add KPV at 200 to 500 mcg per day for additional anti-inflammatory support, particularly if the injury involves significant inflammation
& MacQueen, G